# TRI-LEGEST 21
> **ANDA076405** · Abbreviated New Drug Application (Generic) · Sponsor: BARR · Approved 2007-10-26
## Drug
- **FDA Application Number:** ANDA076405
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRI-LEGEST 21
- **Generic name:** Ethinyl Estradiol
- **Active ingredients:** ETHINYL ESTRADIOL; NORETHINDRONE ACETATE
- **Dosage form:** TABLET
- **Route:** ORAL-21
- **Marketing status:** Discontinued
- **Sponsor:** BARR
- **First approval:** 2007-10-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=076405)
---
*MORVS · CC0 1.0*